...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trading

acchhh,,well,,really,,what else would we expect from RVX management,,they couldnt organize a one car funeral. They have no intention to create liquidity for Zenith shareholders,,,and as we head into the 10th year at being at arms length from our shares. !!

 

Share
New Message
Please login to post a reply